| 滕抗, 陈杰, 邵海燕, 等. 白酒的起源和造酒学刍议[J]. 酿酒科技, 2013, 229(7): 109-112. |
| 孙宝国. 国酒[M]. 北京: 化学工业出版社, 2019. |
| 徐岩, 范文来, 吴群, 等. 风味技术导向白酒酿造基础研究的进展[J]. 酿酒科技, 2012, 211 (1): 17-23. |
| 王琦. 中国白酒文化与行业发展[J]. 食品工业科技, 2017, 38(5): 14-15. |
| 徐岩, 范文来, 葛向阳, 等. 科学认识中国白酒中的生物活性成分[J]. 酿酒科技, 2013, 231(9): 1-6. |
| FANG C, DU H, ZHENG X J, et al. Solid-State Fermented Chinese Alcoholic Beverage (Baijiu) and Ethanol Resulted in Distinct Metabolic and Microbiome Responses[J]. The FASEB Journal, 2019, 33(6): 7274-7288. doi: 10.1096/fj.201802306R |
| 罗强, 刘杰, 刘志刚. 酱香型白酒中活性成分的抗氧化活性[J]. 食品与发酵工业, 2019, 45(23): 84-89. |
| 黄蕴利, 黄永光, 郭旭. 白酒中的主要生物活性功能成分研究进展[J]. 食品工业科技, 2016, 37(15): 375-379. |
| YAO H R, LIU J, PLUMERI D, et al. Lipotoxicity in HepG2 Cells Triggered by Free Fatty Acids[J]. American Journal of Translational Research, 2011, 3(3): 284-291. |
| MORAVCOVÁ A, ČERVINKOVÁ Z, KUČERA O, et al. The Effect of Oleic and Palmitic Acid on Induction of Steatosis and Cytotoxicity on Rat Hepatocytes in Primary Culture[J]. Physiological Research, 2015, 64(suppl 5): 627-636. |
| LI X L, WANG R, ZHOU N, et al. Quercetin Improves Insulin Resistance and Hepatic Lipid Accumulation in Vitro in a NAFLD Cell Model[J]. Biomedical Reports, 2013, 1(1): 71-76. doi: 10.3892/br.2012.27 |
| WU X D, ZHANG L Y, GURLEY E, et al. Prevention of Free Fatty Acid-Induced Hepatic Lipotoxicity by 18β-Glycyrrhetinic Acid through Lysosomal and Mitochondrial Pathways[J]. Hepatology, 2008, 47(6): 1905-1915. doi: 10.1002/hep.22239 |
| GLUCHOWSKI N L, BECUWE M, WALTHER T C, et al. Lipid Droplets and Liver Disease: From Basic Biology to Clinical Implications[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(6): 343-355. doi: 10.1038/nrgastro.2017.32 |
| TESCHKE R. Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance[J]. Biomedicines, 2019, 7(3): 68-79. doi: 10.3390/biomedicines7030068 |
| BYRNE C D, TARGHER G. NAFLD: a Multisystem Disease[J]. Journal of Hepatology, 2015, 62(1): S47-S64. doi: 10.1016/j.jhep.2014.12.012 |
| YOUNOSSI Z, ANSTEE Q M, MARIETTI M, et al. Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention[J]. Nature Reviews Gastroenterology & Hepatology, 2018, 15(1): 11-20. |
| WANG F S, FAN J G, ZHANG Z, et al. The Global Burden of Liver Disease: The Major Impact of China[J]. Hepatology, 2014, 60(6): 2099-2108. doi: 10.1002/hep.27406 |
| 罗欣然, 李秋萍, 舒刚. 保肝口服液对CCl4所致肝损伤小鼠护肝作用评价[J]. 西南师范大学学报(自然科学版), 2021, 46(5): 38-43. |